5 reasons why quality management needs a GxP-regulated cloud
The global shift from traditional IT offerings to cloud services continues
Breaking News
Pfizer’s palbociclib is the top breast cancer drug used in clinical trials initiated in 2018
Breast cancer is the most commonly diagnosed cancer in women and is the fifth largest cause of cancer mortality ...
Adents serialisation solution chosen by French pharma company to ensure FMD compliance
Cloud solution enables Cristers to easily exchange serialisation data with supply chain partners and move beyond ...
Advanced Clinical announces new office location at Partnerships in Clinical Trials Europe
Advanced Clinical is a global clinical development organisation that provides CRO, FSP, quality and validation, and ...
EU GMP Annex 1: What's new for cleaning and disinfection
The revised Annex 1 of the GMP guidelines is close to publication. Here, James Tucker, Ecolab Life Sciences, explores ...
PCI Clinical Services to showcase expertise in Phase I clinical trials in Australia
The global healthcare industry trusts PCI for the drug development solutions that increase their products’ speed to ...
Pharma companies may miss crucial EU drug packaging deadline with a no-deal Brexit
Many EU and US pharma companies are unaware that if a no-deal Brexit is reached between the UK and the EU, they will ...
Serialisation and data connectivity: Part II
The new wrinkle in your supply chain, click here to read part I
New NSF training centre helps medical device makers comply with EU regulations
NSF International's comprehensive EU medical device and pharmaceutical regulatory compliance training is available in a ...
Recipharm’s proprietary molecule Erdosteine recognised as COPD treatment
Recipharm has announced that its proprietary molecule Erdosteine has been officially recognised by the GOLD (Global ...
The Brexit effect and the outlook for 2019
A Q&A with Richard Pether, Director, Rotech
Serialisation and data connectivity: Part I
The new wrinkle in your supply chain
Preparing PIs for post EU-FMD success
Ian Haynes of Excellis Europe explains how the company’s unique approach to enabling collaboration between parallel ...
Asceneuron initiates neuroimaging trial for tau modifier ASN120290
Major milestone in development of novel treatment for progressive supranuclear palsy and other tau-related dementias
CordenPharma announces successful SafeBridge recertification in CordenPharma Colorado
CordenPharma Colorado has successfully completed the potent compound recertification audit by SafeBridge Consultants
In Brief
Most Popular in Regulatory
- Pfizer's palbociclib is the top breast cancer drug used in clinical trials initiated in 2018
- Highly potent APIs: hazards in classification and handling
- European Pharmacopoeia (Ph. Eur.) Commission adopts new monographs and makes a number of revisions
- Adents serialisation solution chosen by French pharma company to ensure FMD compliance
- EU GMP Annex 1: What's new for cleaning and disinfection
Suppliers in regulatory
Reports
